Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Discovery themes featuring this stockAdvanced Enzyme Technologies Ltd (ADVENZYMES) is currently trading at 288.65 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Advanced Enzyme Technologies Limited is the largest Indian enzyme company, specializing in manufacturing and selling enzyme-based solutions across various industries such as human health care, animal nutrition, and food processing. For the third quarter of FY26, the company's revenue grew by 2% year-on-year, showcasing stability despite challenging market conditions. In FY26, the animal nutrition segment performed exceptionally well, increasing revenues by 26% on a year-to-date basis, highlighting its growth potential within the company. The company's strategic acquisitions, including an increased stake in JC Biotech and SciTech Specialities, are aimed at enhancing its biotechnology capabilities and product offerings. Advanced Enzyme Technologies continues to emphasize innovation through significant R&D efforts and has launched new products, including in the human and animal nutrition sectors, indicating its commitment to growth and market expansion.
Over the past 52 weeks, Advanced Enzyme Technologies Ltd has traded between a low of ₹259.70 and a high of ₹366.55. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Advanced Enzyme Technologies Ltd has a market capitalization of approximately 3,304.08. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Advanced Enzyme Technologies Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 21.73 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 3,304.08 Cr, Advanced Enzyme Technologies Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Advanced Enzyme Technologies Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Advanced Enzyme Technologies Ltd is 21.73. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
4
Neutral
6
Bullish
4
Bearish
36
Neutral
6
Bullish
4
Bearish
32
Neutral
0
Bullish
0
Advanced Enzyme Technologies Limited is the largest Indian enzyme company, specializing in manufacturing and selling enzyme-based solutions across various industries such as human health care, animal nutrition, and food processing.
For the third quarter of FY26, the company's revenue grew by 2% year-on-year, showcasing stability despite challenging market conditions.
In FY26, the animal nutrition segment performed exceptionally well, increasing revenues by 26% on a year-to-date basis, highlighting its growth potential within the company.
The company's strategic acquisitions, including an increased stake in JC Biotech and SciTech Specialities, are aimed at enhancing its biotechnology capabilities and product offerings.
Advanced Enzyme Technologies continues to emphasize innovation through significant R&D efforts and has launched new products, including in the human and animal nutrition sectors, indicating its commitment to growth and market expansion.
Pharmaceuticals
Biotechnology
3,304 Cr
Moderate Risk
21.7
60.6
1.7
2.2
366.55
259.70
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
387.00 | 3,342 Cr | 18.70 | 2.38 | 0.00 | 10.96 | 10.33 | 4.37 | |
295.40 | 3,304 Cr | 21.73 | 2.23 | 1.76 | 9.93 | 14.10 | 9.17 | |
347.90 | 2,131 Cr | -289.92 | 2.58 | 0.00 | -5.71 | -5.58 | -0.65 | |
371.90 | 1,527 Cr | 11.30 | 9.17 | 0.11 | 13.86 | 16.04 | 12.18 | |
612.00 | 721 Cr | 9.39 | 2.82 | 0.12 | 10.92 | 16.89 | 7.42 | |
29.00 | 220 Cr | 27.35 | 1.92 | 0.00 | 14.14 | 16.25 | 21.76 | |
98.65 | 199 Cr | 11.93 | 2.30 | 0.00 | 19.49 | 16.44 | 12.65 |
